During the past decade, Taizhou Hospital of Zhejiang Province conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 3 clinical trials were completed, i.e. on average, 7.5% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 3 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Taizhou Hospital of Zhejiang Province" #1 sponsor was "Taizhou Hospital" with 6 trials, followed by "Jiangsu HengRui Medicine Co., Ltd." with 5 trials sponsored, "BeiGene" with 3 trials sponsored, "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 3 trials sponsored and "Betta Pharmaceuticals Co., Ltd." with 3 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Taizhou Hospital of Zhejiang Province" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd" with 1 trials as a collaborator, "Nanjing Medical University" with 1 trials as a collaborator, "National Research Institute for Family Planning, China" with 1 trials as a collaborator and "Taizhou Cancer Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Taizhou Hospital of Zhejiang Province" are "Hypertension" (3 trials), "NSCLC" (3 trials), "Nasopharyngeal Carcinoma" (3 trials), "Hepatitis B, Chronic" (2 trials) and "Abortion, Induced" (1 trials). Many other conditions were trialed in "Taizhou Hospital of Zhejiang Province" in a lesser frequency.

Most popular intervention types in "Taizhou Hospital of Zhejiang Province" are "Drug" (36 trials), "Device" (5 trials), "Procedure" (5 trials), "Other" (4 trials) and "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Alteplase" (2 trials), "Anlotinib" (2 trials), "Docetaxel" (2 trials) and "Extended-Release Carvedilol Sulfate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Taizhou Hospital of Zhejiang Province" are 46 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Taizhou Hospital of Zhejiang Province". undefined are not yet recruiting, 16 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Taizhou Hospital of Zhejiang Province, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Taizhou Hospital of Zhejiang Province, 7 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".